Position in LGVN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$790
-$380 QoQ
Shares Held
112
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 39 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LGVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cornerstone Planning Group LLC holds $333,866 across 46 Biotechnology names. LGVN ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130 | $64,574 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
199 | $37,268 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
389 | $30,447 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
97 | $29,199 | |
| 5 | RPRX |
Royalty Pharma plc
|
373 | $20,914 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 7 | ARGX |
Argenx SE
|
17 | $15,772 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
2,000 | $15,700 |
All Filings in LGVN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $790 | 1,125 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,170 | 1,125 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $569 | 1,125 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $843 | 1,125 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||